Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition in a Rat Model of Neuropathic Pain
Open Access
- 20 December 2006
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 26 (51) , 13318-13327
- https://doi.org/10.1523/jneurosci.3326-06.2006
Abstract
Cannabinoid-based medicines have therapeutic potential for the treatment of pain. Augmentation of levels of endocannabinoids with inhibitors of fatty acid amide hydrolase (FAAH) is analgesic in models of acute and inflammatory pain states. The aim of this study was to determine whether local inhibition of FAAH alters nociceptive responses of spinal neurons in the spinal nerve ligation model of neuropathic pain. Electrophysiological studies were performed 14–18 d after spinal nerve ligation or sham surgery, and the effects of the FAAH inhibitor cyclohexylcarbamic acid 3-carbamoyl biphenyl-3-yl ester (URB597) on mechanically evoked responses of spinal neurons and levels of endocannabinoids were determined.Intraplantar URB597 (25 μg in 50 μl) significantly (p< 0.01) attenuated mechanically evoked responses of spinal neurons in sham-operated rats. Effects of URB597 were blocked by the cannabinoid 1 receptor (CB1) antagonist AM251 [N-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide] (30 μg in 50 μl) and the opioid receptor antagonist naloxone. URB597 treatment increased levels of anandamide, 2-arachidonyl glycerol, and oleoyl ethanolamide in the ipsilateral hindpaw of sham-operated rats. Intraplantar URB597 (25 μg in 50 μl) did not, however, alter mechanically evoked responses of spinal neurons in spinal nerve ligated (SNL) rats or hindpaw levels of endocannabinoids. Intraplantar injection of a higher dose of URB597 (100 μg in 50 μl) significantly (p< 0.05) attenuated evoked responses of spinal neurons in SNL rats but did not alter hindpaw levels of endocannabinoids. Spinal administration of URB597 attenuated evoked responses of spinal neurons and elevated levels of endocannabinoids in sham-operated and SNL rats. These data suggest that peripheral FAAH activity may be altered or that alternative pathways of metabolism have greater importance in SNL rats.Keywords
This publication has 71 references indexed in Scilit:
- The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pHPharmacological Research, 2006
- A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in ratsPAIN®, 2005
- Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophagesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampusNature Neuroscience, 2005
- Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat‐evoked responses of dorsal horn neurons in naïve, carrageenan‐inflamed and neuropathic ratsEuropean Journal of Neuroscience, 2005
- N-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolaseBiochemical Journal, 2004
- Endocannabinoid hydrolasesProstaglandins & Other Lipid Mediators, 2002
- Spinal GABAB-receptor antagonism increases nociceptive transmission in vivoNeuroReport, 2001
- Two distinctive antinociceptive systems in rats with pathological painNeuroscience Letters, 2000
- Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’FEBS Letters, 1995